Sigachi Industries Limited , a leading manufacturer of pharmaceutical excipients, has announced significant developments in its operations and shareholding structure.

New MCC Capacity Expansion

Sigachi Industries has initiated civil works for a new 12,000 MTPA Microcrystalline Cellulose (MCC) project at its Dahej SEZ unit in Gujarat. This strategic expansion is expected to be operational within 9 months and will increase the company's total installed MCC capacity to 30,000 MTPA. The move reinforces Sigachi's position as the largest MCC manufacturer in India and among the top globally.

Enhanced Safety Measures

In light of a recent incident at the company's Pashamylaram unit, Sigachi has emphasized that the new facility will incorporate enhanced safety features. The company is procuring a new Spray Dryer system in consultation with reputed equipment manufacturers and safety experts, demonstrating its commitment to operational excellence and safety.

Amit Raj Sinha, MD & CEO of Sigachi Industries, stated, "The incident at Pashamylaram was a moment of deep sorrow. Yet, Sigachi stands tall— resolute in our values, committed to learning, and determined to build back stronger. This new capacity at Dahej is a testament to that spirit."

Share Pledge Invocation

In a separate development, Sigachi Industries disclosed the invocation of 10,00,000 pledged shares by promoter Amit Raj Sinha to KNAB Finance Advisors Pvt Ltd. This invocation has resulted in a decrease in Sinha's shareholding from 6.15% to 5.90% of the total share capital.

Company Overview

Sigachi Industries Limited manufactures pharmaceutical excipients, APIs, and specialty ingredients across facilities in Telangana, Gujarat, and Karnataka. The company serves customers in over 65 countries and has subsidiaries in the UAE and USA to improve responsiveness to clients.

With this expansion and its global presence, Sigachi Industries continues to strengthen its position in the pharmaceutical excipients market while addressing recent challenges and shareholder changes.

Sigachi Industries Limited, a leading manufacturer of pharmaceutical excipients, APIs, and specialty ingredients, has announced a significant expansion of its microcrystalline cellulose (MCC) manufacturing capacity. The company is set to add a new 12,000 MTPA (metric tonnes per annum) project at its Dahej Special Economic Zone (SEZ) unit in Gujarat, marking a substantial step in its growth strategy.

Expansion Details

The expansion project includes:

• A new 12,000 MTPA MCC capacity at the Dahej SEZ
• Expected to be operational within 9 months
• Advanced Spray Dryer system designed with a focus on safety and excellence
• Consultation with reputed equipment manufacturers and safety experts for the new system

Strategic Importance

This expansion is a key part of Sigachi Industries' long-term vision, emphasizing:

1. Operational Resilience: The new capacity will enhance the company's ability to meet growing demand.
2. Safety-First Design: The project incorporates globally benchmarked safety features.
3. Global Leadership: The expansion will cement Sigachi's position as the largest MCC manufacturer in India and among the top globally.

Capacity Boost

Business Continuity and Customer Service

The new Dahej SEZ facility, along with increased production at existing Jhagadia and Dahej SEZ facilities, will ensure uninterrupted supply to Sigachi's global clientele across 65+ countries.

Management's Perspective

Amit Raj Sinha, MD & CEO of Sigachi Industries, commented on the expansion: "This new capacity at Dahej is a testament to our spirit. It is not just about volumes, but about creating the safest and most reliable excipient manufacturing ecosystem in the world."

Recent Developments

The company acknowledged a recent incident at its Pashamylaram unit, stating that an investigation committee is continuing its work. The new Dahej project reflects Sigachi's determination to strengthen its operations with improved systems and safety measures.

Market Position

Sigachi Industries continues to strengthen its position in the pharmaceutical excipient market:

• Operates 4 multi-locational facilities in Telangana, Gujarat, and Karnataka
• Established subsidiaries in UAE and USA for improved global responsiveness
• Focuses on innovation, quality, and regulatory compliance

This expansion project underscores Sigachi Industries' commitment to growth, safety, and maintaining its leadership in the pharmaceutical excipient industry. As the company moves forward with this significant capacity addition, it aims to enhance its ability to serve the global pharmaceutical and nutrition community while prioritizing operational excellence and safety.